Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Sao Paulo
With
Fundação de Amparo à Pesquisa do Estado de São Paulo
Age
18–70
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Prostate Cancer patients with intermediate or high risk and with indication of radical prostatectomy and LND
Absence of bone metastasis or other organ imaging test (MRI or scintigraphy)
Absence of hormone treatment
Absence of radiotherapy
Signing an informed consent
Availability and adequacy of lymph node tissue samples to perform the immunohistochemical
You may not be if
Life expectancy less than 10 years
Absence of clinical conditions for the procedure
Laparoscopic or perineal surgery
Presence of bone or visceral metastasis
Neoadjuvant treatment
Another malignant neoplasia
Prior abdominal or pelvic surgery
Clareo Health | Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy
